North America continues to hold a leading position in the diabetic retinopathy market, supported by a high prevalence of diabetes, well-established healthcare infrastructure, and increasing adoption of advanced retinal imaging solutions. The region benefits from favorable reimbursement policies, growing public awareness of preventive eye care, and continuous investments in ophthalmic research...